Send feedback

MYO7B p.Arg1755Gln

c.5264G>A · rs190699169 · VCV2651335

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1015 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.764%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate

Computational evidence

Protein change
AlphaMissense0.1015likely benign
REVEL0.44indeterminate
SaProtLLR -8.74tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 8.7GERP 1.3, phastCons 1
Regional constrainto/e 1.07unconstrained · MANE · 7,741 bp · p 0.063 · regional, not allelic
Overall
CADD25.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R1729Q vs ClinVar R1755Q) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.764% European (non-Finnish) · 9,010/1,179,518 alleles
Filtering AF 0.751% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.745%
Overall 0.639% 10,296/1,611,878 alleles · rare exomes 9,642/1,459,498 · genomes 654/152,380 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.988% 101
Amishnot grpmax-eligible 0.877% 114
European (non-Finnish)grpmax 0.764% 131
Middle Eastern 0.611% 164
Remaining individualsnot grpmax-eligible 0.559% 179
Admixed American 0.497% 201
South Asian 0.152% 660
African / African-American 0.14% 715
Finnishnot grpmax-eligible 0.0942% 1,061

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7B
Protein
p.Arg1755Gln
Coding
c.5264G>A
MANE Select
NM_001393586
dbSNP
rs190699169
Type
single nucleotide variant
Location
chr2:127632260 (GRCh38)
Gene constraint
LOEUF 0.956 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 78.34 · 3 PDB
Residue 1729 UniProt numbering
the myth4 2 domain; the 'mediates interaction with cdhr2, cdhr5 and ush1c' region; an α-helix
Full MYO7B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7b-p-arg1755gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown